NEJM and ACC commentators share SMART-DECISION: in patients with preserved ejection fraction at least a year after MI, stopping beta-blockers was noninferior to continuing therapy for major clinical outcomes.
stopping beta-blockers was noninferior to continuing therapy with respect to major clinical outcomes.
SMART-DECISION: more on beta blockers discontinuation!
This finding is one of many signals tracked across Healthcare. The live feed updates every few hours with new expert voices, debates, and emerging ideas.
← Back to Healthcare